Why the Commission is rattled over the Unitary Patent

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Why the Commission is rattled over the Unitary Patent

There is lots happening in Munich this week, as member state representatives gather on Bob-van-Benthem-Platz for a meeting of the Administrative Council on Wednesday. But while much of the focus on the EPO centres on industrial relations and governance issues, there are important Unitary Patent developments taking place too

epo20headquarters20in20munich.jpg

Today members of the select committee of the Admin Council tasked with setting application and renewal fees for the new patent begin their latest two-day meeting.

It is their first since the EPO floated two fee proposals earlier this month. Its so-called TOP4 and TOP5 proposals are based on, respectively, the cost of validating European patents in the most popular four or five member states.

The decision about how much it will cost to apply for and maintain a Unitary Patent was always going to be contentious, since those setting the levels have to reconcile a number of interests – including their own.

Industry has long-championed low fees (no surprise there). But now it seems that IP owners’ unwillingness to use the new system if the figures don’t stack up in their favour has got European Commission officials rattled.

On Friday we reported that senior members of DG Internal Market had shared with the EPO “in no uncertain terms” its view that the level of renewal fees is critical for the success of the system. (You can read more about what officials told us here).

After spending more than 40 years trying to get a pan-European patent right in place, it is easy to understand the bureaucrats’ frustration that it might be stymied from the start by member states keen to maximise their own financial share. The Commission enjoys merely observer status at the select committee meetings. But it is intriguing to think about what its representatives will be saying to member states during the coffee breaks.

Only 30% of our content is published on our blog – to access all of our content you need to be a subscriber. We like to offer our loyal blog readers a special rate, so register your interest in a subscription and we will be in touch shortly.

more from across site and SHARED ros bottom lb

More from across our site

Pedro Moreira outlines proposals by INPI that look set to open a discussion regarding biological materials, extracts, sequences, genetically edited plants, and computer programs
The combined firm, which has a newly appointed IP partner in London, brings together more than 3,500 practitioners across 52 offices, with flagship hubs in Seattle, London, Sydney and New York
A host of SEP-rich law firms, both leading arguments and as intervenors, are set to feature in the UK Supreme Court’s third FRAND episode, though one ground of appeal has been settled
Law firms are investing in generative engine optimisation and boosting their online presence in the hope of gaining a new client base
A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
Gift this article